Cited by 2,049Multiple Sclerosis Research StudiesViral-associated cancers and disordersCytomegalovirus and herpesvirus research

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik, Kjetil, Cortese, Marianna, Healy, Brian C., Kuhle, Jens, Mina, Michael J., Leng, Yumei, Elledge, Stephen J., Niebuhr, David W., Scher, Ann I., Munger, Kassandra L., Ascherio, Alberto·2022·Science

DOI 10.1126/science.abj8222

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Integrity signals

Registry

Crossref · 10.1126/science.abj8222

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Multiple sclerosis
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
The Immune Epitope Database (IEDB): 2018 update
Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T. P., Barcellos, L. F., & Alfredsson, L. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,263
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164
Epstein-Barr virus: exploiting the immune system
Thorley‐Lawson, D. A. (2001) · Nature reviews. Immunology · doi:10.1038/35095584 · Cited by 942

Flagged first, then by citations

Show all 51 references

1 of the 51 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 1,001

Pandemics disable people — the history lesson that policymakers ignore
Spinney, L. (2022) · Nature · doi:10.1038/d41586-022-00414-x · Cited by 20
Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
LoPresti, P. (2022) · Biomedicines · doi:10.3390/biomedicines10051077 · Cited by 21
Framework to Segment and Evaluate Multiple Sclerosis Lesion in MRI Slices Using VGG-UNet
Krishnamoorthy, S., Zhang, Y., Kadry, S., & Yu, W. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/4928096 · Cited by 20
Retracted
Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
Latorre, D. (2022) · European Journal of Immunology · doi:10.1002/eji.202149475 · Cited by 20
CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases
Ruiz-Pablos, M. (2022) · Pathogens · doi:10.3390/pathogens11080831 · Cited by 20
The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model
Hoffman, K. R., Brownell, Z., Doyle, W. J., & Ochoa‐Repáraz, J. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102957 · Cited by 20
Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy
Xie, C., Zhong, L., Bu, G., Zhao, G., Yuan, B., Liu, Y., Sun, C., & Zeng, M. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28793 · Cited by 20
The effects of intermittent fasting for patients with multiple sclerosis (MS): a systematic review
Lin, X., Wang, S., & Gao, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1328426 · Cited by 21
“Current evidence suggests an interplay between genetic susceptibility and environmental factors, potentially triggering aberrant immune responses that result in CNS autoimmune aggression (10–12).”
Background
Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients
Mohammadinasr, M., Montazersaheb, S., Hosseini, V., Kahroba, H., Talebi, M., Molavi, O., Ayromlou, H., & Hejazi, M. S. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156624 · Cited by 20
Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Sheikhi, K., Ghaderi, S., Firouzi, H., Rahimibarghani, S., Shabani, E., Afkhami, H., & Yarahmadi, A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1517369 · Cited by 20
Transcriptomic profiling after B cell depletion reveals central and peripheral immune cell changes in multiple sclerosis
Wei, J., Moon, J., Yasumizu, Y., Zhang, L., Radassi, K., Buitrago-Pocasangre, N., Deerhake, M. E., Strauli, N. B., Chen, C.-W., Herman, A. E., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci182790 · Cited by 27
“…the increase of Treg Eff frequency by both transcriptomic and protein expression, it will be of interest to more precisely identify whether there are differences in myelin-specific and other antigens, as recent studies indicate that EBV infection of B cells is associated with the onset of MS (66).”
Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types
Willard, C., Puglisi, L., Ravì, D., Dmitrieva, M., Mattiesing, R. M., Barkhof, F., Alexander, D. C., Harlow, D. E., Piani-Meier, D., & Eshaghi, A. (2025) · Brain · doi:10.1093/brain/awaf331 · Cited by 21
“In MS, the sNfL level increases at disease onset, 13 is associated with MRI changes of disease activity and neurodegeneration 14 and is sensitive to treatment effects.”
Neurotropic RNA Virus Modulation of Immune Responses within the Central Nervous System
Vazquez, C., & Jurado, K. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074018 · Cited by 19
Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a
Vavougios, G. D., Mavridis, T., Artemiadis, A., Krogfelt, K. A., & Hadjigeorgiou, G. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166430 · Cited by 20
Pediatric Acquired Demyelinating Disorders
Brenton, J. N. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001128 · Cited by 19
Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Hauer, L., & Sellner, J. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s236926 · Cited by 19
RNA ‐binding proteins in autoimmunity: From genetics to molecular biology
Lodde, V., Floris, M., Zoroddu, E., Zarbo, I. R., & Idda, M. L. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1772 · Cited by 19
UV radiation and air pollution as drivers of major autoimmune conditions
Piovani, D., Brunetta, E., & Bonovas, S. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115449 · Cited by 20
Milk polar lipids: Untapped potential for pharmaceuticals and nutraceuticals
Pawar, A., Zabetakis, I., Gavankar, T., & Lordan, R. (2023) · PharmaNutrition · doi:10.1016/j.phanu.2023.100335 · Cited by 19
Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology
Kelley, E., Henson, S. N., Rahee, F., Boyle, A. S., Engelbrektson, A. L., Nelson, G. A., Mead, H., Anderson, N. L., Razavi, M., Yip, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37378-z · Cited by 18
Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis
Zhai, D., Yan, S., Samsom, J., Wang, L., Su, P., Jiang, A., Zhang, H., Jia, Z., Wallach, I., Heifets, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adj6187 · Cited by 19
Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration
Gavilán, E., Medina-Guzman, R., Bahatyrevich-Kharitonik, B., & Ruano, D. (2024) · Cells · doi:10.3390/cells13020123 · Cited by 20
Herpesviridae, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?
Francesco, M. A. D. (2024) · Viruses · doi:10.3390/v16010133 · Cited by 22
Dynamics of the Herpes simplex virus DNA polymerase holoenzyme during DNA synthesis and proof-reading revealed by Cryo-EM
Gustavsson, E., Grünewald, K., Elias, P., & Hällberg, B. M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae374 · Cited by 19
Is EBV the cause of multiple sclerosis?
Giovannoni, G., Hawkes, C. H., Lechner‐Scott, J., Levy, M., Yeh, E. A., & Gold, J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103636 · Cited by 19
Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
Khudainazarova, N. S., Granovskiy, D. L., Kondakova, O. A., Ryabchevskaya, E. M., Kovalenko, A. O., Evtushenko, E. A., Arkhipenko, M. V., Nikitin, N. A., & Karpova, O. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211979 · Cited by 18
Repetitive antigen stimulation in the periphery dictates the composition and recall responses of brain-resident memory CD8+ T cells
Mix, M. R., van de Wall, S., Heidarian, M., Escue, E., Fain, C. E., Pewe, L. L., Hancox, L. S., Arumugam, S. A., Sievers, C. M., Badovinac, V. P., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115247 · Cited by 18
Data linkage multiplies research insights across diverse healthcare sectors
Eisinger‐Mathason, T. S. K., Leshin, J., Lahoti, V., Fridsma, D. B., Mucaj, V., & Kho, A. (2025) · Communications Medicine · doi:10.1038/s43856-025-00769-y · Cited by 18
“Acompellingexampleisastudythatevaluatedmedicalrecords from10millionmilitaryservicepersonnelusingtheDepartmentofDefense (DoD)registry,whichhouseslongitudinalpatientdataandtissuesamples 42 .”
Multiple sclerosis severity variant in DYSF-ZNF638 locus associates with neuronal loss and inflammation
Engelenburg, H. J., van den Bosch, A. M. R., Chen, J. Q. A., Hsiao, C., Melief, M., Harroud, A., Huitinga, I., Hamann, J., & Smolders, J. (2025) · iScience · doi:10.1016/j.isci.2025.112430 · Cited by 18
“30,31 That we do not see our observed increase in protein level of ZNF638 at the transcript level make our findings less certain.”
Detection of viral sequences at single-cell resolution identifies novel viruses associated with host gene expression changes
Luebbert, L., Sullivan, D. K., Carilli, M., Hjörleifsson, K. E., Winnett, A. V., Chari, T., & Pachter, L. S. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02614-y · Cited by 18
“Detect-able viruses have been implicated in heart disease and cancer 4,5 , as well as neurodegenerative disorders such as Alzheimer’s, Parkinson’s and multiple sclerosis 6–8 .”
Inhibition of Th1 activation and differentiation by dietary guar gum ameliorates experimental autoimmune encephalomyelitis
Fettig, N. M., Robinson, H. G., Allanach, J. R., Davis, K. M., Simister, R. L., Wang, E. J., Sharon, A. J., Ye, J., Popple, S., Seo, J. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111328 · Cited by 19
Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis
Comabella, M., Tintoré, M., Sao‐Avilés, A., Carbonell‐Mirabent, P., Malhotra, S., Rovira, À., Fissolo, N., Lünemann, J. D., & Montalbán, X. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330205 · Cited by 18
Dynamics of Viral and Host 3D Genome Structure upon Infection
Friedman, M. J., Lee, H., Kwon, Y., & Oh, S. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2208.08020 · Cited by 20
Tissue‐Targeted Drug Delivery Strategies to Promote Antigen‐Specific Immune Tolerance
Rui, Y., Eppler, H. B., Yanes, A. A., & Jewell, C. M. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202238 · Cited by 17
Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency
Broussard, G. S., Ni, G., Zhang, Z., Li, Q., Cano, P., Dittmer, D. P., & Damania, B. (2023) · Nature Communications · doi:10.1038/s41467-023-35898-2 · Cited by 17
The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection
Rex, V., Zargari, R., Stempel, M., Halle, S., & Brinkmann, M. M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1146381 · Cited by 19
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
Wu, Q., Zhong, L., Wei, D., Zhang, W., Hong, J., Kang, Y., Chen, K., Huang, Y., Zheng, Q., Xu, M., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2245920 · Cited by 18
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Talebi, M., Sadoughi, M. M., Ayatollahi, S. A., Ainy, E., Kiani, R., Zali, A., & Miri, M. M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115805 · Cited by 20
The murine meninges acquire lymphoid tissue properties and harbour autoreactive B cells during chronic Trypanosoma brucei infection
Quintana, J. F., Sinton, M. C., Chandrasegaran, P. R. G., Dubey, L. K., Ogunsola, J. O., Samman, M. A., Haley, M., McConnell, G., Swar, N.-R. K., Ngoyi, D. M., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002389 · Cited by 17
Environmental pollutants and phosphoinositide signaling in autoimmunity
Ren, C., Carrillo, N. D., Cryns, V. L., Anderson, R. A., & Chen, M. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133080 · Cited by 19
EBV and MS: The evidence is growing stronger
Farrell, P. J. (2023) · Cell · doi:10.1016/j.cell.2023.11.023 · Cited by 18
The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis
Sarkar, S. K., Willson, A. M. L., & Jordan, M. A. (2024) · Journal of Immunology Research · doi:10.1155/2024/5383099 · Cited by 19
“…[14], hormones such as estrogen and progesterone [23] and those involved in circadian rhythm like melatonin [24], bacterial and viral infections (particular Epstein – Barr virus) [25, 26], geographical location, i.e., low sunlight and vitamin D [27, 28], in genetically predisposed hosts [14].”
Background
Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression
Liao, Y., Yan, J., Beri, N. R., Giulino-Roth, L. G., Cesarman, E., & Gewurz, B. E. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011939 · Cited by 18
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes
Galipeau, Y., Cooper, C., & Langlois, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1509289 · Cited by 20
Epstein–Barr virus sparks brain autoimmunity in multiple sclerosis
Wekerle, H. (2022) · Nature · doi:10.1038/d41586-022-00382-2 · Cited by 18
What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?
Krämer, J., & Wiendl, H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01246-3 · Cited by 18
The immune system in neurological diseases: what innate‐like T cells have to say
Wyatt-Johnson, S. K., Afify, R., & Brutkiewicz, R. R. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.02.003 · Cited by 17
B cell tolerance and autoimmunity: Lessons from repertoires
Deguine, J., & Xavier, R. J. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231314 · Cited by 19
Current state and perspectives of CAR T cell therapy in central nervous system diseases
Pfeffer, L. K., Fischbach, F., Heesen, C., & Friese, M. A. (2024) · Brain · doi:10.1093/brain/awae362 · Cited by 19
Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression
Ruberto, S., Domínguez‐Mozo, M. I., García‐Martínez, M. Á., Cossu, D., Sechi, L. A., & Álvarez‐Lafuente, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1505239 · Cited by 19
Notch3 destabilizes regulatory T cells to drive autoimmune neuroinflammation in multiple sclerosis
Benamar, M., Contini, P., Schmitz‐Abe, K., Lanzetta, O., Getachew, F., Bachelin, C., Leyva-Castillo, J. M., Wang, M., Öktelik, F. B., Perrot, O., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.09.007 · Cited by 17
Molecular profiling of brain endothelial cell to astrocyte endfoot communication in mouse and human
Hill, S. A., Bravo‐Ferrer, I., Čiulkinytė, A., Ramos, N. P., Rossetti, I., Colvin, C., Beltran-Lobo, P., Parra-Pérez, C., Emelianova, K., Dando, O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65487-4 · Cited by 21
A Final Frontier in Environment-Genome Interactions? Integrated, Multi-Omic Approaches to Predictions of Non-Communicable Disease Risk
Noble, A. J., Purcell, R. V., Adams, A. T., Lam, Y. K., Ring, P. M., Anderson, J. R., & Osborne, A. J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.831866 · Cited by 18
Using MS induced pluripotent stem cells to investigate MS aetiology
Fortune, A. J., Fletcher, J. L., Blackburn, N. B., & Young, K. M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103839 · Cited by 17
Falling down the biological rabbit hole: Epstein-Barr virus, biography, and multiple sclerosis
Horwitz, R. I., Conroy, A. H., Singer, B. H., Cullen, M. R., Badal, K., & Sim, I. (2022) · Journal of Clinical Investigation · doi:10.1172/jci164141 · Cited by 17
Unaltered T cell responses to common antigens in individuals with Parkinson's disease
Williams, G. P., Muskat, K., Frazier, A., Xu, Y., Mateus, J., Grifoni, A., Antunes, R. D. S., Weiskopf, D., Amara, A. W., Standaert, D. G., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120510 · Cited by 17
The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities
Afrasiabi, A., Ahlenstiel, C., Swaminathan, S., & Parnell, G. P. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1454 · Cited by 19
Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy
Rød, B. E., Wergeland, S., Bjørnevik, K., Holmøy, T., Ulvestad, E., Njølstad, G., Myhr, K., & Torkildsen, Ø. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105037 · Cited by 17
Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits
Arunachalam, B. (2024) · Vaccines · doi:10.3390/vaccines12040396 · Cited by 22
“…risk of developing multiple sclerosis (MS), a chronic inflammatory demyelinating disease, by 32-fold compared to persistent EBV seronegative control group; all these MS cases seroconverted for EBV before the onset of MS, as determined by a specific biomarker, clinical manifestation, or both [57].”
Background
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis
Abbadessa, G., Lepore, M. T., Bruzzaniti, S., Piemonte, E., Miele, G., Signoriello, E., Perna, F., Falco, C. D., Lus, G., Matarese, G., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200250 · Cited by 21
An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases
Xu, Y., Wang, Z., Li, S., Su, J., Gao, L., Ou, J., Lin, Z., Luo, O. J., Xiao, C., & Chen, G. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2695-x · Cited by 20
“Bjornevik et al., 2022; Kuchroo and Weiner, 2022; López et al., 2016 IBD Decreased ratio of CD8 + CD28 + T cells to CD8 + CD28 − T cells.”
Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders
Simula, E. R., Jasemi, S., Cossu, D., Fais, M., Cossu, I., Chessa, V., Canu, M., & Sechi, L. A. (2025) · Vaccines · doi:10.3390/vaccines13040415 · Cited by 19
“One of the mechanistic models may be that an initial trigger, such as Epstein–Barr virus infection, recently established as a necessary factor in MS [55], might trans-activate latent HERVs, whose env proteins then sustain chronic CNS inflammation via toll-like receptor signaling and impede…”
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
Spitschak, A., Gupta, S. K., Singh, K. P., Logotheti, S., & Pützer, B. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010083 · Cited by 17
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19Preprint
Maguire, C. P., Chen, J., Rouphael, N., Pickering, H. C., Phan, H. V., Glascock, A. L., Chu, V. T., Dandekar, R., Corry, D. B., Kheradmand, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.14.622799 · Cited by 17
How viral infections cause neuronal dysfunction: a focus on the role of microglia and astrocytes
Hosseini, S., & Korte, M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220771 · Cited by 17
miRNAs in multiple sclerosis: A clinical approach
Minutti-Zanella, C., Bojalil-Álvarez, L., García-Villaseñor, E., López-Martínez, B., PÉREZ-TURRENT, M., Murrieta-Álvarez, I., Ruiz‐Delgado, G. J., & Ruiz-Argüelles, G. J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103835 · Cited by 18
T cell help in the autoreactive germinal center
Akama‐Garren, E. H., & Carroll, M. C. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13192 · Cited by 16
Therapeutic Implications of the Microbial Hypothesis of Mental Illness
Savitz, J. B., & Yolken, R. H. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_368 · Cited by 15
Breastfeeding and Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis of Observational Studies
Holz, A., Riefflin, M., Heesen, C., Riemann-Lorenz, K., Obi, N., & Becher, H. (2022) · Neuroepidemiology · doi:10.1159/000526895 · Cited by 18
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
Saez-Calveras, N., Brewster, A. L., & Stüve, O. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1017484 · Cited by 17
An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis
Kaisey, M., Lashgari, G., Fert‐Bober, J., Ontaneda, D., Solomon, A. J., & Sicotte, N. L. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01227-1 · Cited by 16
Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population
Bingen, J. M., Clark, L., Band, M., Munzir, I., & Carrithers, M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1058817 · Cited by 12
COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels
de Souza, W. D. F., da Fonseca, D. M., & Sartori, A. (2023) · Cells · doi:10.3390/cells12050684 · Cited by 20
Chronic and delayed neurological manifestations of persistent infections
Pandya, D., & Johnson, T. P. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001154 · Cited by 19
Multiple sclerosis: 2023 update
Kuhlmann, T., & Antel, J. P. (2023) · Free Neuropathology · doi:10.17879/freeneuropathology-2023-4675 · Cited by 18
Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1
de la Cruz-Herrera, C. F., Tatham, M. H., Siddiqi, U. Z., Shire, K., Marcon, E., Greenblatt, J. F., Hay, R. T., & Frappier, L. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011477 · Cited by 16
Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review
Lambert, N., Moussaoui, M. E., Baron, F., Maquet, P., & Darcis, G. (2023) · Viruses · doi:10.3390/v15071510 · Cited by 18
Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brain
Thomas, R., Connolly, K. J., Brekk, O. R., Hinrich, A. J., Hastings, M. L., Ole Isacson, A., & Hallett, P. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-41240-z · Cited by 16
Precision Medicine Approach to Alzheimer’s Disease: Rationale and Implications
Bredesen, D. E., Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C. A., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230467 · Cited by 18
Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis
Ban, M., Bredikhin, D., Huang, Y., Bonder, M. J., Katarzyna, K., Oliver, A. J., Wilson, N. K., Coupland, P. G., Hadfield, J., Göttgens, B., et al. (2023) · Brain · doi:10.1093/brain/awad404 · Cited by 15
Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Do, W. L., Wang, L., Forgues, M., Liu, J., Rabibhadana, S., Pupacdi, B., Zhao, Y., Gholian, H., Bhudhisawasdi, V., Pairojkul, C., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101328 · Cited by 16
Analysis of the epidemiology and clinical characteristics of Epstein–Barr virus infection
Ding, B., Zhang, Y., Wu, Y., & Li, Y. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29960 · Cited by 16
“20,21 The autoimmunity of the SLE autoantigen Sm is associated with cross ‐ reactivity with EBV nuclear antigen 1 (EBNA ‐ 1).”
CD4 T cells restricted to DRB1*15:01 recognize two Epstein–Barr virus glycoproteins capable of intracellular antigen presentation
Drosu, N., Anderson, M., Bilodeau, P., Nishiyama, S., Mikami, T., Bobrowski-Khoury, N., Cabot, J., Housman, D., & Levy, M. (2024) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2416097121 · Cited by 13
“Epidemiological evidence has established that Epstein–Barr virus (EBV) is necessary to cause multiple sclerosis (MS) ( 1 ).”
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis
Vasilenko, N., Tieck, M. P., Michel, T., Schembecker, S., Schwarz, P., Guenther, A., Ruschil, C., Poli, S., Ziemann, U., Giede-Jeppe, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1487523 · Cited by 16
The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion
Nash, A., & Ryan, E. J. (2022) · Tumour Virus Research · doi:10.1016/j.tvr.2022.200246 · Cited by 16
Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis
Chatanaka, M. K., Sohaei, D., Diamandis, E. P., & Prassas, I. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2187342 · Cited by 15
EBV-specific T-cell immunity: relevance for multiple sclerosis
Behrens, M., Comabella, M., & Lünemann, J. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1509927 · Cited by 18
Epstein–Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways
Delécluse, S., Baccianti, F., Zala, M., Steffens, A., Drenda, C., judt, D., Holland-Letz, T., Poirey, R., Sujobert, P., & Delecluse, H. (2025) · Nature Communications · doi:10.1038/s41467-025-59813-z · Cited by 16
Type I interferons in health and disease: molecular aspects and clinical implications
Mavragani, C. P., & Crow, M. K. (2025) · Physiological Reviews · doi:10.1152/physrev.00047.2024 · Cited by 16
Exploring epigenetic reprogramming during central nervous system infection
Roy, Z. A. V., & Kielian, T. (2022) · Immunological Reviews · doi:10.1111/imr.13079 · Cited by 14
The enigmatic links between Epstein-Barr virus infection and multiple sclerosis
Tyler, K. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci160468 · Cited by 15
Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation
Lomakin, Y., Zvyagin, I., Ovchinnikova, L. A., Kabilov, M. R., Staroverov, D., Mikelov, A., Tupikin, A., Zakharova, M., Bykova, N., Mukhina, V., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.803229 · Cited by 14
A gene regulatory network approach harmonizes genetic and epigenetic signals and reveals repurposable drug candidates for multiple sclerosis
Manuel, A. M., Dai, Y., Jia, P., Freeman, L. A., & Zhao, Z. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac265 · Cited by 15
Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis
Leffler, J., Trend, S., Hart, P. H., & French, M. A. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1418 · Cited by 15
Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond
Παπαδοπούλου, Α., Alvanou, M., Karavalakis, G., Tzannou, I., & Yannaki, E. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000809 · Cited by 15
Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter study
Martí‐Juan, G., Sastre‐Garriga, J., Martínez‐Heras, E., Vidal‐Jordana, Á., Llufriú, S., Groppa, S., González‐Escamilla, G., Rocca, M. A., Filippi, M., Høgestøl, E. A., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad041 · Cited by 14
Virus-Derived Small RNAs and microRNAs in Health and Disease
Gouzouasis, V., Tastsoglou, S., Giannakakis, A., & Hatzigeorgiou, A. G. (2023) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122220-111429 · Cited by 14
The pathogenesis of multiple sclerosis: a series of unfortunate events
van Noort, J. M., Baker, D., Kipp, M., & Amor, S. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad075 · Cited by 17
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage
Jons, D., Grut, V., Bergström, T. B., Zetterberg, H., Biström, M., Gunnarsson, M., Vrethem, M., Brenner, N., Butt, J., Blennow, K., et al. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-331868 · Cited by 15
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection
Hong, J., Zhong, L., Liu, L., Wu, Q., Zhang, W., Chen, K., Wei, D., Sun, H., Zhou, X., Zhang, X., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101296 · Cited by 15

Authors: Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., & Ascherio, A.
Affiliations: Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Harvard University (US)
Brigham and Women's Hospital (US)
Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Uniformed Services University of the Health Sciences (US)
Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Corresponding author: Cortese, Marianna
Munger, Kassandra L.
Ascherio, Alberto
ORCID: Bjornevik, Kjetil
Cortese, Marianna
Healy, Brian C.
Mina, Michael J.
Leng, Yumei
Elledge, Stephen J.
Munger, Kassandra L.
Ascherio, Alberto
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2022-01-21
Volume: 375
Issue: 6578
Pages: 296-301
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.abj8222
OpenAlex: W4205972999
Cited by: 2,049
References: 51
Citations by year: 2026: 354 · 2025: 412 · 2024: 461 · 2023: 432 · 2022: 388
FWCI: 289.56
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Neurological Disorders and Stroke (R01NS042194, R01NS046635, R01NS103891)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords: multiple sclerosis, Epstein-Barr virus, viral etiology, neurofilament light chain, neuroaxonal degeneration, cytomegalovirus, demyelinating disease, military personnel
MeSH terms: Antibodies, Viral, Cytomegalovirus, Herpesvirus 4, Human, Female, Humans, Longitudinal Studies, Male, Military Personnel, Multiple Sclerosis, Risk Factors, Cohort Studies, Biomarkers, Prevalence, Neurofilament Proteins, Age of Onset, Epstein-Barr Virus Infections, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks